AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2007-10, Vol.21 (10), p.2199-2201
Hauptverfasser:	Schneider, F, Bohlander, S K, Schneider, S, Papadaki, C, Kakadyia, P, Dufour, A, Vempati, S, Unterhalt, M, Feuring-Buske, M, Buske, C, Braess, J, Wandt, H, Hiddemann, W, Spiekermann, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia AML1 protein Cancer Research Core Binding Factor Alpha 2 Subunit - physiology Critical Care Medicine Cytoplasm - metabolism Disease Progression DNA binding proteins DNA-Binding Proteins - physiology Female Gene Expression Regulation, Leukemic Gene mutations Genetic aspects Health aspects Hematology Humans In Situ Hybridization, Fluorescence Intensive Internal Medicine Janus kinase 2 Janus Kinase 2 - physiology letter-to-the-editor Leukemia Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - metabolism Leukemia, Myeloid, Acute - pathology Leukemogenesis Medicine Medicine & Public Health Middle Aged Models, Genetic Mutation Myeloproliferative Disorders - metabolism Myeloproliferative Disorders - pathology Oncology Proto-Oncogene Proteins - physiology RUNX1 Translocation Partner 1 Protein Transcription Factors - metabolism Transcription Factors - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!